These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic collaboration. Purdue University is on the forefront of Pharma 4.0 by partnering ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Too often, the disconnect between a company’s IT department and its business teams slows progress and leads to missed opportunities. In the fast-moving pharmaceutical industry, that can mean the ...

Tariffs are one way for Donald Trump to achieve tax cuts, and Irish-based pharma industry may be a golden goose ready for ...

The pharmaceutical industry avoided immediate tariffs under President Donald Trump’s latest trade actions, though future levies remain a possibility. Here are four things to know: ...

Shares of several major pharmaceutical companies slumped Wednesday morning as President Donald Trump threatened tariffs on ...

In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average target of $3.83, a high estimate of $6.00, and a low estimate of $1.00. This ...